ArticleAntimicrobial agents and chemotherapy2019
Emergence of Carbapenem-Resistant
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 24 citations in OpenAlex.
- Emergence of tet(X6) and blaBMC microbiology · 2026Article
- Emerging reservoirs of metallo-β-lactamase genes among non-Frontiers in microbiology · 2026Article
- Highly carbapenem-resistantMicrobiology spectrum · 2025Article
- Pseudomonas-Enterobacter Co-Infection Drives Cellulitis and Lymphangitis in Equines: A Case Report.Veterinary sciences · 2025Article
- Draft genome sequencing of multidrug-resistantMicrobiology resource announcements · 2024Article
- Evaluation of antimicrobial susceptibility tests for Acinetobacter and Pseudomonas species using disks containing a high dose of meropenem.Scientific reports · 2024Article
- Comparative Genomics ofAntibiotics (Basel, Switzerland) · 2023Article
- Coexistence ofFrontiers in cellular and infection microbiology · 2023Article
- Genomic Epidemiology of MBL-Producing Pseudomonas putida Group Isolates in Poland.Infectious diseases and therapy · 2022Article
- Co-production of Classes A and B Carbapenemases BKC-1 and VIM-2 in a Clinical Pseudomonas Putida Group Isolate from Brazil.Current microbiology · 2022Article
- Whole-Genome Sequencing-Based Re-Identification ofMicrobiology spectrum · 2022Article
- Expression of the qepA1 gene is induced under antibiotic exposure.The Journal of antimicrobial chemotherapy · 2021Article
- Mobile Carbapenemase Genes inFrontiers in microbiology · 2021Review
- Molecular and Functional Characterization of a Novel Plasmid-BorneInfection and drug resistance · 2021Article
- Comprehensive genome data analysis establishes a triple whammy of carbapenemases, ICEs and multiple clinically relevant bacteria.Microbial genomics · 2020Article
- High Level of Resistance to Antimicrobials and Heavy Metals in Multidrug-Resistant Pseudomonas sp. Isolated from Water Sources.Current microbiology · 2020Article
- A multilocus sequence typing scheme of Pseudomonas putida for clinical and environmental isolates.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.